1. Home
  2. ENGN vs SRBK Comparison

ENGN vs SRBK Comparison

Compare ENGN & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

SELL

Current Price

$1.95

Market Cap

117.2M

Sector

N/A

ML Signal

SELL

Logo SR Bancorp Inc.

SRBK

SR Bancorp Inc.

SELL

Current Price

$18.81

Market Cap

138.1M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
ENGN
SRBK
Founded
1999
1887
Country
Canada
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
117.2M
138.1M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
ENGN
SRBK
Price
$1.95
$18.81
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $4.29
N/A
AVG Volume (30 Days)
★ 1.5M
27.2K
Earning Date
12-21-2026
10-26-2026
Dividend Yield
N/A
★ 1.26%
EPS Growth
★ 56.85
N/A
EPS
N/A
★ 0.15
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$126.67
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$14.60
52 Week High
$12.25
$20.95

Technical Indicators

Market Signals
Indicator
ENGN
SRBK
Relative Strength Index (RSI) 55.31 47.37
Support Level $1.61 $18.57
Resistance Level $8.93 $19.07
Average True Range (ATR) 0.18 0.43
MACD 0.07 0.01
Stochastic Oscillator 47.17 45.74

Price Performance

Historical Comparison
ENGN
SRBK

About ENGN enGene Holdings Inc.

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.

About SRBK SR Bancorp Inc.

SR Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers a variety of deposit and loan products to individuals and small businesses, the majority of which are located in its primary market area.

Share on Social Networks: